BRENTUXIMAB VEDOTIN IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED CD30‐POSITIVE PERIPHERAL T‐CELL LYMPHOMAS: REAL‐WORLD DATA
Klanova, M., Sykorova, A., Janikova, A., Mocikova, H., Duras, J., Prochazka, V., Pukyova, J., Klener, P., Belada, D., Kopalova, N., Benesova, K., Campr, V., Blahovcova, P., Trneny, M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Favorable Outcome of High-Risk Mediastinal Diffuse Large B-Cell Lymphoma (DLBCL) after Dose-Intensive Chemotherapy, Rituximab and Autologous Transplant (ASCT)
Pytlik, R., Kubackova, K., Kozak, T., Belada, D., Pirnos, J., Jankovska, M., Pukyova, J., Papajik, T., Siffnerova, H., Zak, P., Vasova, I., Hamouzova, M., Trneny, M.
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article